It is best to have a conversation with your healthcare provider to understand the full scope of the treatment and what the relevant timelines would be based on your health history
Your doctor may consider testing for these conditions based on clinical features rather than as routine screening
Edited by: Aria IM, Jakobi WB, Poppser , Shchacter D, Shafritz D
Has any group looked at head to head diet and exercise (DE) weight loss vs GLP-1s in terms of efficacy, safety, and durability on a pound per pound of fat lost basis
One recent study in patients with psoriasis and psoriatic arthritis found that overweight individuals who combined a GLP-1 agonist with an anti-IL-17 medication experienced both weight loss and improved disease control compared to those using immunosuppressive therapy alone
Predominantly this is a wellbeing treatment